Maastricht, Netherlands

Raed Al Dieri



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Raed Al Dieri in Diagnostic Testing

Introduction

Raed Al Dieri is an accomplished inventor based in Maastricht, Netherlands, known for his significant contribution to medical diagnostics. With a focus on understanding and measuring thrombin activity in biological samples, his work addresses critical needs in both human and animal health.

Latest Patents

Raed Al Dieri holds a patent for a diagnostic test that determines the concentration of transient proteolytic activity in composite biological media. This innovative method allows for real-time monitoring of thrombin activity in blood or plasma samples. The process involves adding a thrombin substrate to measure the activity, while simultaneously utilizing a control sample to establish a baseline. This advanced technique not only aids in diagnosing hyper- and hypo-coagulable states but also provides a comprehensive understanding of thrombin behavior in various conditions, whether congenital, acquired, or drug-induced.

Career Highlights

In his career, Raed has demonstrated a remarkable ability to bridge the gap between innovative research and practical medical applications. Working at Synapse B.V., he has been instrumental in developing technologies that enhance diagnostic capabilities and improve patient care. His expertise in the field of hematology and diagnostics plays a critical role in advancing health outcomes.

Collaborations

Raed Al Dieri collaborates with several esteemed colleagues, including Peter Giesen and Hendrik Coenraad Hemker. These partnerships foster a collaborative environment that drives innovation and promotes research efforts aimed at improving diagnostic tools and methods.

Conclusion

Raed Al Dieri's contributions to diagnostic testing, particularly his patented methods for measuring thrombin activity, demonstrate his commitment to enhancing the field of medical diagnostics. His innovative work not only assists in understanding coagulation disorders but also establishes a foundation for future advancements in the healthcare industry. Through his career and collaborations, Al Dieri continues to impact the medical field positively, showcasing the importance of innovation in addressing real-world health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…